Concepedia

Masao Kuroda

MK

11

Publications

951

Citations

11

H-Index

1976

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Osaka International Cancer Institute

Masao Kuroda is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, biochemistry, and medicine.

Top concepts

BiochemistryPharmacologyMedicineMetabolismHealthPhysiologyBiosynthesisAtherosclerosisPharmacotherapyOxidative Stress

Publications per year

1976–1999

11

Publications

11

Inhibition of Cholesterol Synthesis <i>in vitro</i> and <i>in vivo</i> by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A Reductase

Akira Endo, Yoshio Tsujita, Masao Kuroda et al. · European Journal of Biochemistry · 1977 · 263 citations · Full text

Oxysterol, Pharmacological Study, Biochemistry +15

Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals

Akira Endo, Tsujita Yoshio, Masao Kuroda et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1979 · 217 citations

Metabolic Syndrome, Cholesterol Metabolism, Oxysterol +12

Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits

Yoshio Watanabe, Takashi Ito, Masashi Shiomi et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1988 · 102 citations

Metabolic Syndrome, Pravastatin Sodium, Coronary Atherosclerosis +13

Citrinin, an inhibitor of cholesterol synthesis.

Akira Endo, Masao Kuroda · The Journal of Antibiotics · 1976 · 100 citations · Full text

Impact of tumor size on the clinical outcomes of patients with Robson Stage I renal cell carcinoma

Toshiaki Kinouchi, Shigeru Saiki, Norio Meguro et al. · Cancer · 1999 · 91 citations · Full text

Rows per page

1–5 of 11